Case Report

Published on 11 Mar 2024

Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports

in Cancer Molecular Targets and Therapeutics

Loc Carlo Bao
Alessia Padovan
Andrea Boscolo Bragadin
Lorenzo Calvetti
Valentina Guarneri
Laura Bonanno
Stefano Indraccolo

Frontiers in Oncology

doi 10.3389/fonc.2024.1363069

1,630 views

Review

Published on 08 Mar 2024

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer

in Cancer Molecular Targets and Therapeutics

Linxiang Zhang
Xueying Zhang
Yan Shi
Yuhan Ni
Jiaojiao Fei
Zhixin Jin
Wenjuan Li
Xiaojing Wang
Nan Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1376916

1,692 views
3 citations

Mini Review

Published on 07 Mar 2024

Experimental evidence for anti-metastatic actions of apigenin: a mini review

in Cancer Molecular Targets and Therapeutics

Hyeon-Muk Oh
Chong-Kwan Cho
Nam-Hun Lee
Chang-Gue Son

Frontiers in Oncology

doi 10.3389/fonc.2024.1380194

1,311 views

Original Research

Published on 07 Mar 2024

Sulforaphane inhibits the growth of prostate cancer by regulating the microRNA-3919/DJ-1 axis

in Cancer Molecular Targets and Therapeutics

Fangxi Zhang
Xiaofeng Wan
Jianmin Zhan
Ming Shen
Runsheng Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1361152

1,600 views
1 citation

Review

Published on 06 Mar 2024

Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer

in Cancer Molecular Targets and Therapeutics

Qian Xu
Caiyan Jia
Yan Ou
Chuanxiu Zeng
Yingjie Jia

Frontiers in Oncology

doi 10.3389/fonc.2024.1371421

5,552 views
1 citation

Mini Review

Published on 04 Mar 2024

The TGF-β superfamily as potential therapeutic targets in pancreatic cancer

in Cancer Molecular Targets and Therapeutics

Rachel R. Tindall
Jennifer M. Bailey-Lundberg
Yanna Cao
Tien C. Ko

Frontiers in Oncology

doi 10.3389/fonc.2024.1362247

2,569 views

Correction

Published on 29 Feb 2024

Corrigendum: Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3

in Cancer Molecular Targets and Therapeutics

Halima Alsamri
Hussain El Hasasna
Yusra Al Dhaheri
Ali H. Eid
Samir Attoub
Rabah Iratni

Frontiers in Oncology

doi 10.3389/fonc.2023.1235201

1,013 views

Review

Published on 28 Feb 2024

Expression and prognosis of ADAMTS18 in different tumors

in Cancer Molecular Targets and Therapeutics

Wenfei Guo
Yuying Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1347633

1,208 views

Editorial

Published on 28 Feb 2024

Editorial: Integrating transcriptional modulation in systemic tumor therapy

in Cancer Molecular Targets and Therapeutics

Daniel Heudobler
Florian Lüke
Lina Ghibelli
Albrecht Reichle

Frontiers in Oncology

doi 10.3389/fonc.2024.1385766

775 views

Systematic Review

Published on 28 Feb 2024

A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals

in Cancer Molecular Targets and Therapeutics

D. Robert Paval
Thomas G. Di Virgilio
Richard J. E. Skipworth
Iain J. Gallagher

Frontiers in Oncology

doi 10.3389/fonc.2024.1198555

1,340 views

Review

Published on 26 Feb 2024

Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay

in Cancer Molecular Targets and Therapeutics

Huiming Zhang
Naifeng Chen
Chenglong Ding
Huinan Zhang
Dejiang Liu
Shuang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1344290

3,644 views
3 citations

Mini Review

Published on 26 Feb 2024

In vitro and in vivo modeling systems of supratentorial ependymomas

in Cancer Molecular Targets and Therapeutics

Emily A. Hatanaka
Joshua J. Breunig

Frontiers in Oncology

doi 10.3389/fonc.2024.1360358

1,522 views

Original Research

Published on 26 Feb 2024

Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro

in Cancer Molecular Targets and Therapeutics

Natália V. Segatto
Lucas D. Simões
Camila B. Bender
Fernanda S. Sousa
Thais L. Oliveira
Júlia D. F. Paschoal
Bruna S. Pacheco
Isadora Lopes
Fabiana K. Seixas
Aisha Qazi

Frontiers in Oncology

doi 10.3389/fonc.2024.1323422

1,878 views
1 citation

Correction

Published on 22 Feb 2024

Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway

in Cancer Molecular Targets and Therapeutics

Xin Wen
Si Chen
Xueting Chen
Hui Qiu
Wei Wang
Nie Zhang
Wanming Liu
Tingting Wang
Xin Ding
Longzhen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1381151

634 views

Review

Published on 21 Feb 2024

Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review

in Cancer Molecular Targets and Therapeutics

Yingjun Zhang
Ge Zhang
Yuefang Wang
Lei Ye
Luyun Peng
Rui Shi
Siqi Guo
Jiajing He
Hao Yang
Qingkai Dai

Frontiers in Oncology

doi 10.3389/fonc.2024.1324859

1,813 views
2 citations

Case Report

Published on 06 Feb 2024

Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary MET amplification/overexpression and EGFR mutation

in Cancer Molecular Targets and Therapeutics

Xiaolin Ren
Kejie Li
Yang Zhang
Changlin Zou
Meng Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1297156

1,300 views

Navigation group

Articles

Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer

Experimental evidence for anti-metastatic actions of apigenin: a mini review

Sulforaphane inhibits the growth of prostate cancer by regulating the microRNA-3919/DJ-1 axis

Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer

The TGF-β superfamily as potential therapeutic targets in pancreatic cancer

Corrigendum: Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3

Expression and prognosis of ADAMTS18 in different tumors

Editorial: Integrating transcriptional modulation in systemic tumor therapy

A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals

Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay

In vitro and in vivo modeling systems of supratentorial ependymomas

Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro

Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway

Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review

Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary MET amplification/overexpression and EGFR mutation